1130 related articles for article (PubMed ID: 20298391)
1. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
2. Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.
Dahl M; Tybjaerg-Hansen A; Lange P; Nordestgaard BG
Respir Res; 2005 Oct; 6(1):113. PubMed ID: 16212675
[TBL] [Abstract][Full Text] [Related]
3. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
4. Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity.
Lee J; Nordestgaard BG; Dahl M
Respir Med; 2009 Sep; 103(9):1286-92. PubMed ID: 19423314
[TBL] [Abstract][Full Text] [Related]
5. Markers of early disease and prognosis in COPD.
Dahl M; Nordestgaard BG
Int J Chron Obstruct Pulmon Dis; 2009; 4():157-67. PubMed ID: 19436688
[TBL] [Abstract][Full Text] [Related]
6. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin?
Troelsen LN; Garred P; Jacobsen S
J Rheumatol; 2010 Mar; 37(3):536-43. PubMed ID: 20110521
[TBL] [Abstract][Full Text] [Related]
7. Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections.
Yang IA; Seeney SL; Wolter JM; Anders EM; McCormack JG; Tunnicliffe AM; Rabnott GC; Shaw JG; Dent AG; Kim ST; Zimmerman PV; Fong KM
Genes Immun; 2003 Jun; 4(4):269-74. PubMed ID: 12761563
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
9. Genetics of chronic obstructive pulmonary disease.
Silverman EK
Novartis Found Symp; 2001; 234():45-58; discussion 58-64. PubMed ID: 11199103
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein and risk of venous thromboembolism in the general population.
Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1672-8. PubMed ID: 20466978
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
[TBL] [Abstract][Full Text] [Related]
12. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
[TBL] [Abstract][Full Text] [Related]
13. Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease.
Eagan TM; Aukrust P; Bakke PS; Damås JK; Skorge TD; Hardie JA; Ueland T; Mollnes TE
Respir Med; 2010 Feb; 104(2):283-90. PubMed ID: 19836222
[TBL] [Abstract][Full Text] [Related]
14. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
15. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants.
Ottaviani S; Gorrini M; Scabini R; Kadija Z; Paracchini E; Mariani F; Ferrarotti I; Luisetti M
Transl Res; 2011 Jun; 157(6):332-8. PubMed ID: 21575917
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and the risk of cancer: a mendelian randomization study.
Allin KH; Nordestgaard BG; Zacho J; Tybjaerg-Hansen A; Bojesen SE
J Natl Cancer Inst; 2010 Feb; 102(3):202-6. PubMed ID: 20056955
[TBL] [Abstract][Full Text] [Related]
17. The new genetics and chronic obstructive pulmonary disease.
Kalsheker N; Chappell S
COPD; 2008 Aug; 5(4):257-64. PubMed ID: 18671150
[TBL] [Abstract][Full Text] [Related]
18. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population.
Marott SC; Nordestgaard BG; Zacho J; Friberg J; Jensen GB; Tybjaerg-Hansen A; Benn M
J Am Coll Cardiol; 2010 Aug; 56(10):789-95. PubMed ID: 20797493
[TBL] [Abstract][Full Text] [Related]
19. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
20. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.
Dahl M; Nordestgaard BG; Lange P; Tybjaerg-Hansen A
J Allergy Clin Immunol; 2001 May; 107(5):818-23. PubMed ID: 11344348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
